| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
14,457 |
11,575 |
$562K |
| 99457 |
|
2,495 |
2,283 |
$36K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
219 |
219 |
$20K |
| 99490 |
Ccm add 20min |
1,422 |
1,362 |
$18K |
| 99215 |
Prolong outpt/office vis |
356 |
284 |
$16K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
524 |
447 |
$13K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
332 |
303 |
$11K |
| 94644 |
|
453 |
299 |
$9K |
| 20611 |
|
296 |
258 |
$8K |
| 95912 |
|
63 |
63 |
$7K |
| 94660 |
|
417 |
383 |
$7K |
| 94060 |
|
308 |
298 |
$7K |
| 94729 |
|
285 |
281 |
$6K |
| 94726 |
|
286 |
282 |
$6K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
170 |
69 |
$4K |
| 96415 |
|
332 |
303 |
$4K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
145 |
129 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
542 |
426 |
$2K |
| 96367 |
|
173 |
109 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
127 |
110 |
$2K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
80 |
29 |
$2K |
| 92512 |
|
60 |
59 |
$1K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
266 |
232 |
$1K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
316 |
259 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
994 |
666 |
$869.65 |
| 94375 |
|
128 |
121 |
$661.67 |
| 94010 |
|
129 |
122 |
$572.08 |
| 94200 |
|
86 |
75 |
$534.32 |
| 93000 |
|
65 |
65 |
$468.79 |
| G0008 |
Administration of influenza virus vaccine |
67 |
60 |
$369.28 |
| 1125F |
|
3,165 |
2,699 |
$173.00 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
303 |
189 |
$159.10 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
303 |
189 |
$156.02 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
14 |
12 |
$148.04 |
| Q2037 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) |
13 |
13 |
$113.20 |
| 99439 |
|
14 |
14 |
$100.86 |
| 90674 |
|
22 |
17 |
$93.00 |
| 99497 |
|
14 |
12 |
$86.72 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
57 |
52 |
$86.69 |
| 94150 |
|
65 |
61 |
$74.06 |
| J1956 |
Injection, levofloxacin, 250 mg |
27 |
14 |
$40.23 |
| 90688 |
|
17 |
15 |
$31.86 |
| G0446 |
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes |
15 |
12 |
$14.35 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
15 |
12 |
$10.68 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
64 |
27 |
$4.20 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
955 |
824 |
$0.00 |
| 2000F |
|
621 |
580 |
$0.00 |
| 1036F |
|
2,444 |
2,003 |
$0.00 |
| 1126F |
|
82 |
75 |
$0.00 |
| 3080F |
|
88 |
84 |
$0.00 |
| 1123F |
|
14 |
12 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
459 |
432 |
$0.00 |
| 1170F |
|
45 |
40 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
855 |
745 |
$0.00 |
| 3077F |
|
519 |
490 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
1,255 |
1,087 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
15 |
12 |
$0.00 |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
15 |
13 |
$0.00 |
| 3288F |
|
14 |
12 |
$0.00 |
| 1100F |
|
14 |
12 |
$0.00 |
| G8842 |
Apnea hypopnea index (ahi), respiratory disturbance index (rdi) or respiratory event index (rei) documented or measured within 2 months after initial evaluation for suspected obstructive sleep apnea |
14 |
12 |
$0.00 |
| 0518F |
|
14 |
12 |
$0.00 |